Improving anticoagulant use for prevention of venous thromboembolism
- Improving anticoagulant use for prevention of venous thromboembolism. // American Journal of Health-System Pharmacy;5/15/2010 Supplement, Vol. 67, pS31
The article presents a lesson plan for continuing education, which teaches concepts on the use of anticoagulant to prevent venous thromboembolism.
- Clinical and management challenges in preventing venous thromboembolism in health systems: A case-based panel discussion. Haines, Stuart T.; Dager, William E.; Trujillo, Toby C. // American Journal of Health-System Pharmacy;5/15/2010 Supplement, Vol. 67, pS26
Purpose. To illustrate clinical and management issues in the prevention of venous thromboembolism (VTE) in health systems. Summary. Lack of evidence to guide the choice among available anticoagulants and the dosing, timing of initiation, and duration of therapy for VTE prevention in certain...
- Emerging anticoagulants for venous thromboembolism prevention. Trujillo, Toby C. // American Journal of Health-System Pharmacy;5/15/2010 Supplement, Vol. 67, pS17
Purpose. To discuss the advantages and disadvantages of currently available anticoagulants, describe the characteristics of the ideal anticoagulant, and compare and contrast the mechanisms of action, pharmacokinetics, administration, efficacy, safety, and potential for drug interactions of...
- Aspirin and venous thromboembolism. // OB/GYN Clinical Alert;Jul2012, Vol. 29 Issue 3, p2
The article offers information regarding the use of aspirin which can be protective for patients who had venous thromboembolism in preventing it to reoccur after oral anticoagulant therapy.
- Therapeutic Index of Anticoagulants for Prevention of Venous Thromboembolism Following Orthopedic Surgery: A Dose-Response Meta-Analysis. Mandema, J W; Boyd, R A; DiCarlo, L A // Clinical Pharmacology & Therapeutics;Dec2011, Vol. 90 Issue 6, p820
Information on the comparative effectiveness of drugs is crucial for drug development decisions, in addition to being needed by regulators, prescribers, and payers. We have carried out a dose-response meta-analysis of three end points each for efficacy and bleeding for various anticoagulants...
- Working Toward a System-wide Venous Thromboembolism Prophylaxis Strategy: Experience From a Multisite Health Region. Semchuk, William; Kolodziejak, Lynette; Bubbar, Carolyn; Poulin, Susan // Hospital Pharmacy;Aug2011, Vol. 46 Issue 8, p574
Background: Venous thromboembolism (VTE), comprised of both deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common complication for hospitalized patients. Clear guidance is available to practitioners in regard to risk factors for the development of VTE as well as strategies to...
- Prophylactic Anticoagulant Therapy in the Orthopedic Patient. Neu Jr., Leo T.; Waterfield, Jim R.; Ash, Charles J. // Annals of Internal Medicine;Mar65, Vol. 62 Issue 3, p463
Focuses on a study of orthopedic patients who suffered trauma of the pelvis and lower extremities, to determine the value of routine prophylactic warfarin sodium anticoagulation in the prevention of thromboembolic phenomena. Significance of the variation between anticoagulated patients from the...
- Heparin prophylaxis has no benefit in medical patients. Snee, Michael // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/4/2012, Vol. 345 Issue 7868, p29
The article discusses about the heparin prophylaxis for venous thromboembolism (VTE). The study found that deep vein thrombosis (DVT) in medical patients cannot to prevented and also found there is no benefit for heparin prophylaxis. The counselling given to the medical patients are highlighted.
- Aspirin given for up to 2 years after initial anticoagulant treatment reduces the risk of venous thromboembolism recurrence without increasing risk of major bleeding. Watson, Henry G. // Evidence Based Nursing;Jul2013, Vol. 16 Issue 3, p92
The article discusses a study on the reduction of the risk of venous thromboembolism recurrence without increasing risk of major bleeding after stopping the intake of salicylate drug aspirin for 2 years after initial anticoagulant treatment. It states that a randomised controlled study compared...